HEmorrhoidAl Disease in Inflammatory Bowel Disease: a Multicenter Prospective Cohort Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTreviso Regional Hospital
About this trial
Patients who will undergo surgery for HD after the diagnosis of IBD over a 12-month period will be enrolled across Europe.
Primary objective of this study is to determine the safety and effectiveness of surgical treatments for HD in a large multicenter cohort of IBD patients.
Secondary aim is to identify factors that may affect clinical and surgical outcomes.
Eligibility criteria
Qualifiers
age of 18 years and above;
established diagnosis of Crohn's disease or ulcerative colitis at the time of surgery for hemorrhoidal disease;
planned surgery for hemorrhoidal disease during the study period, including hemorrhoidectomy (open, close or submucosal), transanal hemorrhoidal dearterialization, hemorrhoidal laser procedure, stapled hemorrhoidopexy).
Disqualifiers
previous surgery for hemorrhoidal disease other than office-based treatments (e.g., sclerotherapy injection, rubber band ligation);
active perianal disease at the time of surgical intervention.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov